TB-500 (Frag 17–23) — 10 mg

TB-500 (Fragment 17–23), also referred to as the “active site” of Thymosin Beta-4, is a short peptide sequence (LKKTETQ) believed to be responsible for much of TB-500’s regenerative potential. It is studied for its roles in wound healing, tissue repair, angiogenesis, and inflammation balance.

Benefits

• Wound healing — studied for accelerating closure and tissue regeneration.
• Cell migration — explored for promoting actin-binding activity essential in repair.
• Angiogenesis — linked to formation of new blood vessels in recovery models.
• Inflammation balance — studied for reducing excess inflammatory response.
• Targeted activity — represents the functional “core” of TB-500 in a smaller peptide fragment.

What researchers look at

• Fragment 17–23 (LKKTETQ) vs. full-length TB-500 activity.
• Binding to actin and promoting cytoskeletal reorganization.
• Preclinical studies on wound healing, angiogenesis, and regeneration.
• Potential for targeted applications with reduced peptide size.

Quick Specs

• Form: Lyophilized peptide
• Net per vial: 10 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

Identity Basics

• Sequence: LKKTETQ
• Formula / M.W.: C₃₆H₆₆N₁₀O₁₃, ~889 Da
• CAS: 476014-70-7

Selected Research

• Thymosin Beta-4 peptide fragments and repair activity:
  
  https://pubmed.ncbi.nlm.nih.gov/11336780/
  
• Role of LKKTETQ motif in actin binding:
  
  https://pubmed.ncbi.nlm.nih.gov/16432249/
  
• Tissue regeneration and angiogenesis research:
  
  https://pubmed.ncbi.nlm.nih.gov/19433835/
  

⚠️ Disclaimer

• This product is intended for laboratory research use only.

• Not for human or veterinary use.

• Not approved for diagnostic, therapeutic, or medical applications.

• Handle using appropriate laboratory safety procedures and personal protective equipment.